209 related articles for article (PubMed ID: 20180364)
1. [Cytomegalovirus primary infection in a patient with Crohn's disease treated with azathioprine and anti-TNF alpha].
Ben Hriz F; Habbessi H; Maamouri N; Belkahla N; Ouerdiane S; Chouaib S; Ouerghi H; Chaabouni H; Ben Mami N
Tunis Med; 2009 Aug; 87(8):545-6. PubMed ID: 20180364
[No Abstract] [Full Text] [Related]
2. Fatal disseminated cytomegalovirus infection associated with infliximab and 6-mercaptopurine therapy in a child with Crohn disease.
Pickering O; Weinstein T; Rubin LG
Pediatr Infect Dis J; 2009 Jun; 28(6):556. PubMed ID: 19483533
[No Abstract] [Full Text] [Related]
3. [Therapy of chronic inflammatory bowel diseases. TNF-alpha blocker in Crohn disease: earlier use is rewarding].
MMW Fortschr Med; 2008 Dec; 150(51-52):54-5. PubMed ID: 19156959
[No Abstract] [Full Text] [Related]
4. Closing fistulas in Crohn's disease--should the accent be on maintenance or safety?
Fiocchi C
N Engl J Med; 2004 Feb; 350(9):934-6. PubMed ID: 14985492
[No Abstract] [Full Text] [Related]
5. Combining infliximab with 6-mercaptopurine/azathioprine for fistula therapy in Crohn's disease.
Ochsenkühn T; Göke B; Sackmann M
Am J Gastroenterol; 2002 Aug; 97(8):2022-5. PubMed ID: 12190171
[TBL] [Abstract][Full Text] [Related]
6. Steroid-independent Crohn's disease patients also benefit from combination therapy of infliximab plus azathioprine.
van den Brande JM; Peppelenbosch MP; Hommes DW
Gastroenterology; 2006 Oct; 131(4):1362-3. PubMed ID: 17030216
[No Abstract] [Full Text] [Related]
7. Long-term partial remission of autoimmune thrombocytopenia in a patient treated with the anti-tumor necrosis factor-alpha antibody infliximab for refractory fistulizing Crohn's disease.
de Rossi TM; Krauss N; Voll RE; Nägel A; Weidenhiller M; Konturek PC; Hahn EG; Raithel M
Digestion; 2008; 78(4):195-200. PubMed ID: 19122456
[TBL] [Abstract][Full Text] [Related]
8. Longstanding Crohn's vulvitis successfully treated with combined anti-TNFα antibody and azathioprine.
Macdonagh E; Pugh S; Fox R
J Obstet Gynaecol; 2013 Jul; 33(5):530. PubMed ID: 23815219
[No Abstract] [Full Text] [Related]
9. Treatment of patients with Crohn's disease and concomitant chronic hepatitis C with a chimeric monoclonal antibody to TNF.
Holtmann MH; Galle PR; Neurath MF
Am J Gastroenterol; 2003 Feb; 98(2):504-5. PubMed ID: 12591081
[No Abstract] [Full Text] [Related]
10. Extra-intestinal Hodgkin's lymphoma in a Crohn's disease patient on long-term azathioprine and infliximab therapy.
Dahhan T; Al Kahtani K; Bakshi N; Abouzied ME; Helmy A
Trop Gastroenterol; 2010; 31(1):51-3. PubMed ID: 20860231
[No Abstract] [Full Text] [Related]
11. Early postoperative recurrence of severe Crohn's disease, with colonic involvement and associated human cytomegalovirus infection, treated with oral valganciclovir and adalimumab.
Sinagra E; Renna S; Mocciaro F; Olivo M; Cottone M; Orlando A
Inflamm Bowel Dis; 2011 Jun; 17(6):E43-4. PubMed ID: 21438099
[No Abstract] [Full Text] [Related]
12. [Top-down versus Step-Up: new strategies in the treatment of Crohn's disease].
Meier J; Sturm A
Z Gastroenterol; 2009 Feb; 47(2):240-2. PubMed ID: 19197829
[No Abstract] [Full Text] [Related]
13. High serum tumor necrosis factor-alpha levels are associated with lack of response to infliximab in fistulizing Crohn's disease.
Martínez-Borra J; López-Larrea C; González S; Fuentes D; Dieguez A; Deschamps EM; Pérez-Pariente JM; López-Vázquez A; de Francisco R; Rodrigo L
Am J Gastroenterol; 2002 Sep; 97(9):2350-6. PubMed ID: 12358255
[TBL] [Abstract][Full Text] [Related]
14. [Miliary tuberculosis in a patient with Crohn's disease].
Ferrer I; Maroto N; Montón C; Villagrasa R; López A; Clofent J; Hinojosa J
Gastroenterol Hepatol; 2011; 34(7):511-3. PubMed ID: 21737181
[No Abstract] [Full Text] [Related]
15. Prediction of response to infliximab in Crohn's disease.
Chaudhary R; Ghosh S
Dig Liver Dis; 2005 Aug; 37(8):559-63. PubMed ID: 15893967
[No Abstract] [Full Text] [Related]
16. Cytomegalovirus colitis complicating ulcerative colitis treated with adalimumab.
Charles P; Ackermann F; Burdy G; Blétry O; Leport J; Kahn JE
Scand J Gastroenterol; 2010 Apr; 45(4):509-10. PubMed ID: 20095878
[No Abstract] [Full Text] [Related]
17. Infliximab treatment induces levels of the active azathioprine metabolite TGTP in Crohn's disease.
Teichgräber U; Atreya I; Atreya R; Schwab M; Neurath MF
Inflamm Bowel Dis; 2013; 19(4):E54-5. PubMed ID: 22532373
[No Abstract] [Full Text] [Related]
18. Management of Crohn's disease--a practical approach.
Knutson D; Greenberg G; Cronau H
Am Fam Physician; 2003 Aug; 68(4):707-14. PubMed ID: 12952387
[TBL] [Abstract][Full Text] [Related]
19. [Hodgkin's lymphoma in a patient with Crohn's disease treated with azathioprine and antibodies anti tumor necrosis factor α].
Sagüés M; Navarro JT; Ribera JM; Millá F
Med Clin (Barc); 2012 Apr; 138(8):366-7. PubMed ID: 21752407
[No Abstract] [Full Text] [Related]
20. Appropriateness of therapy for fistulizing Crohn's disease: findings from a national inflammatory bowel disease cohort.
Pittet V; Juillerat P; Michetti P; Vader JP; Burnand B; Rogler G; Beglinger C; Seibold F; Mottet C; Felley C; Gonvers JJ; Froehlich F;
Aliment Pharmacol Ther; 2010 Oct; 32(8):1007-16. PubMed ID: 20937046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
